| 000 | 01821 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513092456.0 | ||
| 264 | 0 | _c19960820 | |
| 008 | 199608s 0 0 eng d | ||
| 022 | _a0022-5347 | ||
| 024 | 7 |
_a10.1097/00005392-199608000-00008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSoloway, M S | |
| 245 | 0 | 0 |
_aUse of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. _h[electronic resource] |
| 260 |
_bThe Journal of urology _cAug 1996 |
||
| 300 |
_a363-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xurine |
| 650 | 0 | 4 |
_aCarcinoma, Transitional Cell _xdiagnosis |
| 650 | 0 | 4 | _aConfidence Intervals |
| 650 | 0 | 4 | _aCystoscopy |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdiagnosis |
| 650 | 0 | 4 |
_aNuclear Proteins _xurine |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aROC Curve |
| 650 | 0 | 4 | _aReagent Kits, Diagnostic |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdiagnosis |
| 700 | 1 | _aBriggman, V | |
| 700 | 1 | _aCarpinito, G A | |
| 700 | 1 | _aChodak, G W | |
| 700 | 1 | _aChurch, P A | |
| 700 | 1 | _aLamm, D L | |
| 700 | 1 | _aLange, P | |
| 700 | 1 | _aMessing, E | |
| 700 | 1 | _aPasciak, R M | |
| 700 | 1 | _aReservitz, G B | |
| 700 | 1 | _aRukstalis, D B | |
| 700 | 1 | _aSarosdy, M F | |
| 700 | 1 | _aStadler, W M | |
| 700 | 1 | _aThiel, R P | |
| 700 | 1 | _aHayden, C L | |
| 773 | 0 |
_tThe Journal of urology _gvol. 156 _gno. 2 Pt 1 _gp. 363-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00005392-199608000-00008 _zAvailable from publisher's website |
| 999 |
_c8681506 _d8681506 |
||